Results 141 to 150 of about 22,628,682 (367)

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

Molecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma, Sophia M. Orbach, Kate V. Griffin, Kathryn Kang, Yining Zhang, Rebecca S. Pereles, Ian A. Schrack, Guillermo Escalona, Jacqueline S. Jeruss, Lonnie D. Shea   +9 more
wiley   +1 more source

The Behavior Change Technique Taxonomy (v1) of 93 Hierarchically Clustered Techniques: Building an International Consensus for the Reporting of Behavior Change Interventions

Annals of Behavioral Medicine, 2013
S. Michie, M. Richardson, M. Johnston, C. Abraham, J. Francis, W. Hardeman, M. Eccles, J. Cane, Caroline E. Wood   +8 more
semanticscholar   +1 more source

The Geological Survey's work on development of prospecting tools, instruments, and techniques [PDF]

, 1952
Frank W. Stead
openalex   +1 more source

On the Jacopini Technique

Information and Computation, 1997
AbstractThe general concern of the Jacopini technique is the question: “Is it consistent to extend a given lambda calculus with certain equations?” The technique was introduced by Jacopini in 1975 in his proof that in the untyped lambda calculusΩis easy, i.e.,Ωcan be assumed equal to any other (closed) term without violating the consistency of the ...
openaire   +3 more sources

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

Molecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu, Katherine Eason, Suet‐Feung Chin, Paul A. W. Edwards, Raquel Manzano Garcia, Richard Moulange, Jia Wern Pan, Soo Hwang Teo, Sach Mukherjee, Maurizio Callari, Carlos Caldas, Stephen‐John Sammut, Oscar M. Rueda   +12 more
wiley   +1 more source

McClung's Handbook of Microscopical Technique [PDF]

, 1951
R. J. V. Pulvertaft
openalex   +3 more sources

ELECTRODIAGNOSTIC TECHNIQUES

Australian Journal of Physiotherapy, 1968
The first application of electricity to the study of excitability of nerve and muscle was at the latter half of the 19th Century when Erb (1883) described the galvanic-faradic test. Lord Adrian was the first to demonstrate the clinical application of strength-duration curves, and they became widely used in the assessment of peripheral nerve injuries ...
openaire   +2 more sources

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

Molecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci, Izzet Akiva, Yavuz Hakan Ozon, Hakan Berkil, Huseyin Karadayi, Omer Dizdar, Suayib Yalcin   +6 more
wiley   +1 more source

Tools and Techniques

, 2011
In software engineering, tools and techniques are essential for many purposes. They can provide guidance to follow a certain software development process or a selected software lifecycle model. They can support various stakeholders in validating the compliance of the development results against quality criteria spanning from technical non-functional ...
Lago, P., Avgeriou, P., Grundy, J., Hall, J., Mistrik, I.   +4 more
openaire   +3 more sources

Landscape of BRAF transcript variants in human cancer

Molecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda, Danilo Tatoni, Gianluca Mattei, Alberto Magi, Romina D'Aurizio, Laura Poliseno   +5 more
wiley   +1 more source